Find your path to Anja
418 people in our graph share verified history with Anja — schools, employers, funds. One of them is your warm intro.
Mike ZakunlockedAnja: together at Cornell (1995–2000)
×7Anja: together at Cornell
Anja: together at Sensirion
×2Anja: together at Mediar Therapeutics
Experience
- NovartisGlobal Head Novartis Venture Fundcurrent2017 — presentBasel, Basel, Switzerland
- NovartisManaging Director Novartis Venture Fund2007 — 2017
- NovartisStrategic Assistant to Chairman and CEO2006 — 2007Basel, Basel, Switzerland
- SensirionIndependent Board Director (Verwaltungsrat)current2021 — presentZürich Metropolitan Area
- InnosuisseDirector Board of Directorscurrent2025 — presentSwitzerland
- Mediar TherapeuticsBoard Director2023 — 2025Boston, Massachusetts, United States
- SNSF Swiss National Science FoundationMember of the Board of Trustees (Stiftungsrat and Stiftungsratsausschuss)2021 — 2024Berne, Switzerland
- Forendo Pharma LtdBoard Director2014 — 2021Turku, Southwest Finland, Finland
- ArctosBoard Director2020 — 2021Basel, Switzerland
- Ribon TherapeuticsBoard Director2019 — 2021Greater Boston
- ETH ZürichInvestment Committee Member2019 — 2021Zurich, Switzerland
- University of ZurichBoard Director of UZH Life Sciences Fund2017 — 2020
- BRIDGE Programm (SNSF-Innosuisse)Steering Committee Member and POC Jury2018 — 2019Bern Area, Switzerland
- Bicycle TherapeuticsBoard Director2009 — 2019Cambridge, United Kingdom
- ANAVEON AGBoard Director2018 — 2019Basel, Switzerland
- BaseLaunchJury member2016 — 2018Basel, Basel, Switzerland
- Cutiss AGBoard director2017 — 2018Zurich, Switzerland
- F2GBoard director2011 — 2018Manchester Area, United Kingdom
- Sosei HeptaresBoard Director2009 — 2015London, Greater London, United Kingdom
- Covagen AGBoard Director2007 — 2014Zurich, Switzerland
- Nabriva Therapeutics plcBoard Director2008 — 2013Vienna, Vienna, Austria
- MerLion Pharmaceuticals Pte LtdBoard director2007 — 2009Singapore
Skills & more
Board of DirectorsVenture Capital52Biotechnology23Life Sciences5Technology Transfer5Pharmaceutical Industry4Mergers & Acquisitions17M&A experience2Medical Devices7Strategy5Lifesciences5Start-ups5
+11 more
Corporate DevelopmentDue DiligenceCommercializationManagement ConsultingCross-functional Team LeadershipClinical DevelopmentStrategic PlanningDrug DevelopmentResearch and Development (R&D)Financial ModelingBiopharmaceuticalsFrom Anja's professional profile.
Deals · 1
Mediar TherapeuticsBoard seat
via Novartis Venture Fund · filed Oct 2024 · $85M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Investor
Bicycle TherapeuticsCovagenDiagnoplexF2GForendo PharmaNabriva TherapeuticsOxagenPharmAbcine
Sources: SEC Form D filings · curated public sources.
Colleagues at Novartis Venture Fund
Adam Cotton
Principal at the Novartis Venture Fund
Anís
Head of Scoping, Pharma at Deep Science Ventures
Anja König
Global Head at Novartis Venture Fund
Bart Dzikowski
Managing Director, Head of Transactions & Legal at Novartis Venture Fund
Beat Steffen
Managing Director at Novartis Venture Fund
Campbell Murray
Advisor
Christoph Meier
Investor at Novartis Venture Fund
Elaine Jones
Investor at Novartis Venture Fund
Network5
Aaron Nelson
Partner at Novo Holdings
Bart Dzikowski
Managing Director, Head of Transactions & Legal at Novartis Venture Fund
Beat Steffen
Managing Director at Novartis Venture Fund
Elena Battistello
Analyst at Novartis Venture Fund
Florian Muellershausen
Managing Director at Novartis Venture Fund
Investors connected to Anja in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Anja Koenig?
- Global Head of NVF at Novartis Venture Fund
- Where does Anja Koenig work?
- Anja Koenig is Global Head of NVF at Novartis Venture Fund.
- What boards does Anja Koenig sit on?
- Anja Koenig holds tracked board seats at Mediar Therapeutics.
- What companies has Anja Koenig invested in?
- Investments tracked here include Bicycle Therapeutics, Covagen, Diagnoplex, F2G, Forendo Pharma, Nabriva Therapeutics, Oxagen, PharmAbcine.
- Where did Anja Koenig go to school?
- Anja Koenig studied at Cornell University (PhD, Physics); Ludwig-Maximilians-Universität München (Masters (Diplom), Physics); University of Oxford (Physics).
Same school
Also attended Cornell University1,397
Jenny LeeSenior Managing Partner at Granite AsiaNeeraj AgrawalGeneral Partner at Battery VenturesJohn ZimmerCo-founder of LyftMichelle FernandesInvestor at Index VenturesMike ZakInvestor at CRV (Charles River Ventures)Micah RosenbloomGeneral Partner at Founder Collective
+ 1,391 more
Also attended Ludwig-Maximilians-Universität München241
Julia SchrameierAssociate at Manta Ray VenturesCeline XiaoInvestor at DN CapitalFriedrich von WulffenPrincipal at Burda Principal InvestmentsElçinTalent Team at Hummingbird VenturesLaura WeigertSenior Associate at Marlin Equity PartnersToby TriebelPartner at FinTech Collective
+ 235 more
Also attended University of Oxford1,752
Reid HoffmanCo-founder of LinkedIn; Partner at GreylockMichael MoritzFormer Partner at Sequoia Capital; Senior Adviser at Sequoia HeritageGabriel PereyraCo-founder & President of HarveyDominic JacquessonInvestor at Index VenturesErin Price-WrightInvestor at Index VenturesJan HammerInvestor at Index Ventures
+ 1,746 more
Shared employers
Also worked at Innosuisse21
Martin ScherrerPartner & Head of Managed Funds at RedstoneReinhard VoelkelInvestor at Sand Hill AngelsAnja KönigGlobal Head at Novartis Venture FundMichael WackerManaging Partner at BioMedPartnersAndreas JurgeitPartner at GimvMichael SidlerFounding Partner at redalpine
+ 15 more
Also worked at Ribon Therapeutics8
Marian NakadaVice President, Venture Investments at JJDCAnja KönigGlobal Head at Novartis Venture FundJeff GoaterPartner at The Column GroupChristian SchubertHead of AbbVie Ventures at AbbVieJodie MorrisonVenture Partner at Atlas VentureEdward Tad StewartChief Business Officer at Matrisome Bio
+ 2 more
Also worked at Bicycle Therapeutics7
Michael AnsteyPartner at Cambridge Innovation CapitalAnja KönigGlobal Head at Novartis Venture FundCatherine StaceVP - Strategic Relationships at O2h VenturesAlex LeechPartner, Biovelocita Strategy at Sofinnova PartnersNIGEL CROCKETTExecutive Officer at BicycleMICHAEL SKYNNERExecutive Officer at Bicycle
+ 1 more























































